| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 514 | 2024 |
| Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 M Naghavi, SE Vollset, KS Ikuta, LR Swetschinski, AP Gray, EE Wool, ... The Lancet 404 (10459), 1199-1226, 2024 | 379 | 2024 |
| Importance of probiotics in the prevention and treatment of colorectal cancer M Eslami, B Yousefi, P Kokhaei, M Hemati, ZR Nejad, V Arabkari, ... Journal of cellular physiology 234 (10), 17127-17143, 2019 | 300 | 2019 |
| Probiotics importance and their immunomodulatory properties B Yousefi, M Eslami, A Ghasemian, P Kokhaei, A Salek Farrokhi, ... Journal of cellular physiology 234 (6), 8008-8018, 2019 | 268 | 2019 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 225 | 2024 |
| Sensing properties of BN nanotube toward carcinogenic 4-chloroaniline: a computational study M Eslami, V Vahabi, AA Peyghan Physica E: Low-dimensional Systems and Nanostructures 76, 6-11, 2016 | 150 | 2016 |
| A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system S Yasamineh, P Yasamineh, HG Kalajahi, O Gholizadeh, Z Yekanipour, ... International journal of pharmaceutics 624, 121878, 2022 | 138 | 2022 |
| A global treatments for coronaviruses including COVID‐19 B Yousefi, S Valizadeh, H Ghaffari, A Vahedi, M Karbalaei, M Eslami Journal of cellular physiology 235 (12), 9133-9142, 2020 | 138 | 2020 |
| Probiotics function and modulation of the immune system in allergic diseases M Eslami, A Bahar, M Keikha, M Karbalaei, NM Kobyliak, B Yousefi Allergologia et Immunopathologia 48 (6), 771-788, 2020 | 129 | 2020 |
| DNA nucleobase interaction with graphene like BC3 nano-sheet based on density functional theory calculations M Eslami, AA Peyghan Thin Solid Films 589, 52-56, 2015 | 97 | 2015 |
| Are probiotics useful for therapy of Helicobacter pylori diseases? M Eslami, B Yousefi, P Kokhaei, AJ Moghadas, BS Moghadam, ... Comparative immunology, microbiology and infectious diseases 64, 99-108, 2019 | 92 | 2019 |
| Epigenetic changes in gastric cancer induction by Helicobacter pylori B Yousefi, M Mohammadlou, M Abdollahi, A Salek Farrokhi, M Karbalaei, ... Journal of cellular physiology 234 (12), 21770-21784, 2019 | 83 | 2019 |
| HCV genotypes and their determinative role in hepatitis C treatment M Keikha, M Eslami, B Yousefi, M Ali-Hassanzadeh, A Kamali, M Yousefi, ... VirusDisease, 1-6, 2020 | 66 | 2020 |
| Importance of the microbiota inhibitory mechanism on the Warburg effect in colorectal cancer cells M Eslami, S Sadrifar, M Karbalaei, M Keikha, NM Kobyliak, B Yousefi Journal of gastrointestinal cancer 51, 738-747, 2020 | 60 | 2020 |
| Mycobacterium avium paratuberculosis and Mycobacterium avium complex and related subspecies as causative agents of zoonotic and occupational diseases M Eslami, M Shafiei, A Ghasemian, S Valizadeh, AH Al‐Marzoqi, ... Journal of cellular physiology 234 (8), 12415-12421, 2019 | 59 | 2019 |
| Potential antigen candidates for subunit vaccine development against Helicobacter pylori infection M Keikha, M Eslami, B Yousefi, A Ghasemian, M Karbalaei Journal of cellular physiology 234 (12), 21460-21470, 2019 | 56 | 2019 |
| Risk factors and control strategies for silicotuberculosis as an occupational disease M Shafiei, A Ghasemian, M Eslami, F Nojoomi, H Rajabi-Vardanjani New Microbes and New Infections 27, 75-77, 2019 | 56 | 2019 |
| Current information on the association of Helicobacter pylori with autophagy and gastric cancer M Eslami, B Yousefi, P Kokhaei, V Arabkari, A Ghasemian Journal of cellular physiology 234 (9), 14800-14811, 2019 | 53 | 2019 |
| Probiotics and their increasing importance in human health and infection control A Ghasemian, M Eslami, M Shafiei, S Najafipour, A Rajabi Reviews and Research in Medical Microbiology 29 (4), 153-158, 2018 | 47 | 2018 |
| Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD) M Hemmati, S Kashanipoor, P Mazaheri, F Alibabaei, A Babaeizad, S Asli, ... Life Sciences 329, 121947, 2023 | 46 | 2023 |
